Subscribe
17 March 2016Big Pharma

GSK chief executive to step down in 2017

Pharmaceutical company GSK has announced to shareholders that its chief executive (CEO) Sir Andrew Witty will be retiring from his role in 2017.

GSK released a statement today, March 17 revealing the news.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Africa
GSK to widen access to medicines in world’s poorest countries
1 April 2016   Pharmaceutical company GSK has adopted a new approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.


Editor's picks

Americas
Bernie Sanders blasts big pharma for ‘ripping off’ patients
8 February 2024

Editor's picks

Americas
Bernie Sanders blasts big pharma for ‘ripping off’ patients
8 February 2024
Americas
Pfizer and BioNTech allege inconsistencies in Moderna’s COVID-19 statements
1 February 2024
Biotechnology
Force pharma companies to provide drugs for rare cancer trials, UK govt told
30 January 2024
Biotechnology
USPTO hands win to Daiichi Sankyo in cancer drug dispute
18 January 2024
Americas
SCOTUS urged to remedy ‘threat’ to patent law in sleep drug feud
16 January 2024
Big Pharma
SCOTUS rejects big pharma’s challenge to USPTO power
9 January 2024

More on this story

Africa
GSK to widen access to medicines in world’s poorest countries
1 April 2016   Pharmaceutical company GSK has adopted a new approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.

More on this story

Africa
GSK to widen access to medicines in world’s poorest countries
1 April 2016   Pharmaceutical company GSK has adopted a new approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.

More features

US agency warns 10 pharma companies of filing ‘bogus’ patents
BioNTech’s patent juggling act: protecting innovation amid IP challenges
USPTO veteran joins Finnegan as of counsel in Washington, DC
CureVac and Acuitas wind up COVID-19 vaccine dispute
Amgen and Sandoz settle dispute over blockbuster bone condition drugs
GSK: Pfizer, BioNTech ‘reaped billions of dollars’ from stealing COVID-19 patents
GSK settles HIV drug licensing dispute
Meeting the cell and gene therapy scale-up challenge